Moderna Inc. (MRNA) - 5i Research

Moderna Inc. (MRNA $48.71)
- $48.71 Cap: $19.02B
- View MRNA Profile
- View Questions on MRNA

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $344.75)
- $344.75 P/E (TTM): 26.8X Cap: $185.64B
- View AMGN Profile
- View Questions on AMGN
CVS Health Corporation (CVS $83.01)
- $83.01 P/E (TTM): 217.58X Cap: $105.37B
- View CVS Profile
- View Questions on CVS
Johnson & Johnson (JNJ $220.14)
- $220.14 P/E (TTM): 21.09X Cap: $530.38B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $100.88)
- $100.88 P/E (TTM): 27.39X Cap: $129.32B
- View MDT Profile
- View Questions on MDT
Moderna Inc. (MRNA $48.71)
- $48.71 Cap: $19.02B
- View MRNA Profile
- View Questions on MRNA

Q: I am building a diversified portfolio of healthcare stocks. I own JNJ, AMGN, MDT, CVS and MRNA. These are 2.9%, 3.8%, 2.5%, 4% and 0.5% of my portfolio respectively. Is this a high quality portfolio? Would you recommend any changes?

Read Answer Asked by David on October 08, 2025

Amgen Inc. (AMGN $344.75)
- $344.75 P/E (TTM): 26.8X Cap: $185.64B
- View AMGN Profile
- View Questions on AMGN
PayPal Holdings Inc. (PYPL $56.62)
- $56.62 P/E (TTM): 11.5X Cap: $52.97B
- View PYPL Profile
- View Questions on PYPL
AbbVie Inc. (ABBV $219.26)
- $219.26 P/E (TTM): 166.5X Cap: $387.51B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $1,064.29)
- $1,064.29 P/E (TTM): 53.2X Cap: $1T
- View LLY Profile
- View Questions on LLY
Progressive Corporation (The) (PGR $206.03)
- $206.03 P/E (TTM): 11.35X Cap: $120.81B
- View PGR Profile
- View Questions on PGR
Prologis Inc. (PLD $127.15)
- $127.15 P/E (TTM): 36.82X Cap: $118.10B
- View PLD Profile
- View Questions on PLD
Moderna Inc. (MRNA $48.71)
- $48.71 Cap: $19.02B
- View MRNA Profile
- View Questions on MRNA
Enphase Energy Inc. (ENPH $39.46)
- $39.46 P/E (TTM): 27.73X Cap: $5.16B
- View ENPH Profile
- View Questions on ENPH
BioNTech SE (BNTX $115.98)
- $115.98 Cap: $27.83B
- View BNTX Profile
- View Questions on BNTX

Q: Given the potential for a market down-turn, do you see any of these as a good buy for a long-term investment?

Read Answer Asked by Camille on August 01, 2025

Abbott Laboratories (ABT $107.42)
- $107.42 P/E (TTM): 13.63X Cap: $186.78B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $1,064.29)
- $1,064.29 P/E (TTM): 53.2X Cap: $1T
- View LLY Profile
- View Questions on LLY
Pfizer Inc. (PFE $25.65)
- $25.65 P/E (TTM): 15.17X Cap: $145.83B
- View PFE Profile
- View Questions on PFE
Novo Nordisk A/S (NVO $62.26)
- $62.26 P/E (TTM): 17.68X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Moderna Inc. (MRNA $48.71)
- $48.71 Cap: $19.02B
- View MRNA Profile
- View Questions on MRNA

Q: Hello,

Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.

Thank you!

Read Answer Asked by Irek on February 14, 2025